University of Maryland, Baltimore;Regeneron Pharmaceuticals, Inc.
发明人:
Da-Wei Gong,James A. Perry,Alan Shuldiner,Nehal Gosalia,Cristopher Van Hout
申请号：
US16823832
公开号：
US20200297753A1
申请日:
2020.03.19
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides methods of treating subjects having increased lipid levels and/or increased triglyceride levels, methods of identifying subjects having an increased risk of developing an increased lipid level and/or increased triglyceride level, methods of detecting human Sterol Regulatory Element Binding Protein Cleavage-Activating Protein (SCAP) variant nucleic acid molecules and variant polypeptides, and SCAP variant nucleic acid molecules and variant polypeptides.
